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AIM OF THE STUDY
METHODOLOGY
INTRODUCTION
Formaldehyde (FA) is a colourless gas widely used in the industry and hospitals as an aqueous solution, formalin. It is extremely reactive and
induces various genotoxic effects in proliferating cultured mammalian cells.
Tobacco smoke has been epidemiologically associated to a higher risk of development of cancer, especially in the oral cavity, larynx and
lungs, as these are places of direct contact with many carcinogenic tobacco’s compounds. Genetic polymorphisms in enzymes involved in the
metabolism are very important and can make changes in the individual susceptibility to disease. Alcohol dehydrogenase class 3 (ADH3), also
known as formaldehyde dehydrogenase dependent of glutathione, is the major enzyme involved in the formaldehyde oxidation, especially in
the buccal mucosa. The polymorphism in study is a substitution of an isoleucine for a valine in codon 349.
The cytokinesis-blocked micronucleus assay (CBMN) in human lymphocytes is one of the most commonly used methods for measuring DNA
damage, namely the detection of micronucleus, nucleoplasmic bridges, and nuclear buds, classified as genotoxicity biomarkers.
RESULTS
CONCLUSIONS
Determine whether there is an in vivo association between
genetic polymorphism of the gene ADH3 and the frequency of
genotoxicity biomarkers in occupationally workers exposed to
formaldehyde and with or without tobacco consumption.
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The study was carried out in Portugal in a sample of 56 workers
occupationally exposed to FA in pathology anatomy laboratories and in
85 non-exposed subjects. Both groups were asked about their smoking
habits among other items. The evaluation of genotoxic effects was
conducted by applying CBMN in peripheral blood lymphocytes and the
MN test in exfoliated cells from buccal mucosa. To perform the
genotype analysis of ADH3 Ile349Val polymorphism, the target fragment
was amplified using specific primers: Forward (5’-
GCTTTAAGAGTAAATATTCTGTCCCC-3’) e Reverse (5’-
AATCTACCTCTTTCCSGAGC-3’) and it was used PCR-RFLP. After, the
digested products were analyzed in 4% agarose gel with ethide
bromide. The data were analyzed statistically using Logistic Regression
and Kruskal-Wallis test.
The results concerning the lymphocytes suggest that MN in lymphocytes, NPB and NBUD are significantly associated with FA exposure          
(p< 0,001) but not with tobacco smoke. The results concerning the MN in buccal mucosa cells indicate that the FA exposure (p=0,012) and 
tobacco smoke (p=0,028) increase this biomarker but not in a synergist way. About the polymorphisms of ADH3, were found statistically 
significant, with the exception for NPB and MN in buccal cells. The polymorphism ADHE Ile/Val has a protective role in MN in lymphocytes and 
NBUD in comparison with Val/Val polymorphism. The analysis of the interaction between tobacco and FA exposure demonstrate that the 
absence of tobacco smoke in exposed to FA has a protective factor in NPB (p=0,000). There weren’t observed any significant associations 
between tobacco consumption and FA exposure. 
The development of biomarkers is one avenue to improved measurement of exposure, genetic susceptibility and disease. The majority of the 
single nucleotide polymorphisms in human genome are of low penetrance, including genes implicated in metabolism of chemicals. It is 
important to take into account that FA exerts its genotoxic action upon exposed human cells (both local and distant) and despite the 
potentially deleterious biological consequences outlined above, FA continues to be commercially utilized for disinfection, preservation and 
sterilization purposes.
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Exposed Controls
MN lymphocytes
NPB
NBUD
MN buccal cells
Groups ADH3 N Mean MN 
lymphocytes ±
S.E.
Mean NPB±
S.E.
Mean 
NBUD± S.E.
Mean MN buccal 
cells ± S.E.
Exposed Ile/Ile 15 4.44±0.974
(0-12)
4.00±0.811
(1-13)
1.33±0.361
(0-5)
1.53±0.710
(0-9)
Ile/Val 34 4.00±0.723
(0-14)
2.59±0.722
(0-15)
0.47±0.185
(880-2)
0.68±0.301
(0-8)
Val/Val 4 4.75±1.436
(3-9)
3.35±2.287
(0-10)
1.50±0.645
(0-2)
2.00±1.080
(0-5)
Controls Ile/Ile 17 0.65±0.296
(0-4)
0.20±0.074
(0-2)
0.06±0.059
(0-1)
0.24±0.16
(0-2)
Ile/Val 56 0.70±0.215
(0-7)
0.11±0.111
(0-3)
0.07±0.035
(0-1)
0.14±0.65
(0-2)
Val/Val 9 2.00±0.645
(0-6)
0.06±0.059
(0-1)
0.11±0.111
(0-1)
0.22±0.222
(0-2)
Table 1 – Descriptive statistics for genotoxcity biomarkers means according to ADH3 Ile349Val 
polymorphisms
Figure 1 – Distribution of the genotoxcity biomarkers according to ADH3 Ile349Val polymorphisms
